Actively Recruiting
Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice
Led by Seung-Jung Park · Updated on 2026-01-02
2000
Participants Needed
1
Research Sites
154 weeks
Total Duration
On this page
Sponsors
S
Seung-Jung Park
Lead Sponsor
C
CardioVascular Research Foundation, Korea
Collaborating Sponsor
AI-Summary
What this Trial Is About
The objective of this study is to evaluate the effectiveness and safety of XIENCE Skypoint stents in comparison to other drug-eluting stents (DES) in real-world practice.
CONDITIONS
Official Title
Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 19 years old or older
- Patients receiving XIENCE Skypoint stents
- Patients or guardians who agree to the study protocol, follow-up schedule, and provide informed, written consent approved by an Institutional Review Board or Ethics Committee
You will not qualify if you...
- Patients receiving a mixture of other drug-eluting stents
- Patients with a terminal illness and life expectancy less than 1 year
- Patients experiencing cardiogenic shock
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Asan Medical Hospital
Seoul, South Korea
Actively Recruiting
Research Team
J
Jung-hee Ham, Project manager
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here